Planta Med 1984; 50(5): 420-424
DOI: 10.1055/s-2007-969753
Research Articles

© Georg Thieme Verlag Stuttgart · New York

Comparative Pharmacological Study of Sparteine and its Ketonic Derivative Lupanine from Seeds of Lupinus albus

Kokou Yovo1 , François Huguet2 , 4 , Jacques Pothier3 , Marc Durand3 , Michel Breteau1 , Guy Narcisse2
  • 1Laboratoire de Pharmacologie et Toxicologic cliniques, U.E.R. de médecine, F-37000 Tours, France
  • 2Laboratoire d'Hygiène-Toxicologie, U.E.R. des Sciences Pharmaceutiques et Institut du Médicament de Tours, France
  • 3Laboratoire de Pharmacognosie, U.E.R. des Sciences Pharmaceutiques, Tours, France
  • 4François Huguet, Institut du Médicament de Tours, rue Joseph Cugnot, B.P. 253, F-37702 St. Pierre des Corps, France
Further Information

Publication History

1984

1984

Publication Date:
26 February 2007 (online)

Abstract

The pharmacological properties of lupanine (ketonic derivative of sparteine) isolated from seeds of Lupinus albus, in comparison with sparteine were investigated. Ganglioplegic activities and affinity for cholinergic receptors were studied. Lupanine is more efficient than sparteine for antagonizing secondary reflex hypertension in carotid occlusion and hypotension resulting from the stimulation of the pneumogastric nerve in both the cat and the dog. Furthermore, lupanine is much less toxic in one single injection in both the mouse and the guinea-pig. The two substances have an identical inhibitory action on nicotinic type hypertension produced by injection of acetylcholine (500 µg/ kg i.v.) in the atropine-treated dog. The in vitro binding study confirms the selectivity on nicotinic sites with similar affinities for the two drugs. Differences in the bio-availability and the pharmacokinetics of the two alkaloids are presumed. Lupanine may diffuse and disappear more rapidly in ganglia than sparteine.

    >